Form 8-K - Current report:
SEC Accession No. 0001178670-25-000062
Filing Date
2025-05-13
Accepted
2025-05-13 17:01:36
Documents
14
Period of Report
2025-05-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K alny-20250508.htm   iXBRL 8-K 51220
2 EX-3.1 exhibit31alnylamcertificat.htm EX-3.1 9154
  Complete submission text file 0001178670-25-000062.txt   195397

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alny-20250508.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alny-20250508_lab.xml EX-101.LAB 23451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alny-20250508_pre.xml EX-101.PRE 13581
17 EXTRACTED XBRL INSTANCE DOCUMENT alny-20250508_htm.xml XML 3042
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 25941144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)